Bone News and Research

RSS

Percutaneous ethanol injection helps manage bone metastasis in thyroid cancer patients

Percutaneous ethanol injection (PEI), an injection of ethanol (alcohol) through the skin directly into a bone tumor to kill cancer cells, may be a valuable ancillary treatment for thyroid cancer patients whose cancer has spread to the bone.

5 Jun 2007

Surgery best for degenerative spondylolisthesis with spinal stenosis

In one of the three most common back conditions for which patients seek treatment, surgery proved to have substantially better results than non-surgical remedies, according to Dartmouth-led research published in the May 31 New England Journal of Medicine.

1 Jun 2007

New center for the treatment of sarcoma at Cedars-Sinai

A new center for the treatment of sarcoma, a type of cancer that affects bone and soft tissue, will open on June 12 at Cedars-Sinai Medical Center's Samuel Oschin Comprehensive Cancer Institute.

1 Jun 2007

Breakthrough in stem cell banking

Scientists from the Research Department of Cryo-Save Group NV together with the University of Cologne (DE) have developed a new scientifically validated method to collect adult mesenchymal stem cells ("MSCs") from the lining of umbilical cord tissue.

1 Jun 2007

Existence of muscle-building stem cells points to regenerative therapies for muscular disease

A new report in the June 1 issue of the journal Cell, a publication of Cell Press, confirms the existence of some apparently uncommitted stem cells amongst cells responsible for generating the bulging biceps of body builders and the rippling abs of fitness buffs.

1 Jun 2007

U.S. government prevents meat packer testing for mad cow disease

In what is being seen by many as a curious and in some ways surprising move, the U.S. government is trying to prevent a Kansas meat packer from testing all of their animals for Mad Cow disease.

31 May 2007

Coping with side effects from pelvic radiotherapy

Cancer patients about to undergo pelvic radiotherapy or who have had the treatment and are experiencing some of the potentially worrying and embarrassing side effects, now have a new free resource to turn to thanks to Cancerbackup and Cancer Research UK.

30 May 2007

Community-associated antibiotic-resistant staph infections increase

The incidence of antibiotic-resistant staph infections associated with being acquired in the community and not in health care institutions increased almost seven-fold in Chicago's Cook County Hospital system between 2000 and 2005, according to a report in the Archives of Internal Medicine.

30 May 2007

Depression is a risk factor for osteoporosis

Evidence is accumulating that depression is a risk factor for osteoporosis, reports the June 2007 issue of Harvard Women's Health Watch.

30 May 2007

New method predicts hip joint decay from chemotherapy

St. Jude investigators say they have found the best way for predicting when patients will need future surgery to repair hip joints that have deteriorated because of pediatric leukemia or lymphoma treatment.

27 May 2007

Stem cells may look malignant, not act it

Call it the cellular equivalent of big glasses, a funny nose and a fake mustache.

24 May 2007

New tool-kit to educate doctors on osteoporosis

Researchers at the Garvan Institute of Medical Research are developing a tool-kit to educate doctors on osteoporosis and provide them with a focussed set of effective, easy-to-use risk factor tests that will lead directly to preventive programs designed to reduce the risk and impact of the condition.

24 May 2007

Surgeries to treat urinary incontinence in women

The University of California, San Diego Medical Center along with nine other clinical research institutions across the United States has completed the largest randomized clinical trial to date comparing two commonly performed surgical procedures to treat urinary stress incontinence.

22 May 2007

Artificially created bone tissue

As the nation ages, an estimated 44 million Americans, including at least half of those ages 50 and older, are at risk for osteoporosis, making their bones fragile and vulnerable to serious fractures.

22 May 2007

Link between periodontitis and tongue cancer

Researchers at the University at Buffalo and Roswell Park Cancer Institute have shown for the first time that an association exists between long-standing periodontitis, or gum disease, and risk of tongue cancer.

22 May 2007

FDA in trouble over widely used diabetic drug Avandia

A diabetes pill which has been widely used since 1999 is now suspected of increasing the risk of heart attacks for those taking it.

22 May 2007

Patients with myelodysplastic syndromes treated with Revlimid are living longer and remaining transfusion independent

New updated results from a pivotal Phase II trial evaluating Revlimid in patients with an incurable blood cancer known as myelodysplastic syndromes (MDS) were presented by Dr. Alan List, from the H. Lee Moffitt Cancer Center & Research Institute, at the 9th International Symposium on MDS currently taking place in Florence, Italy.

18 May 2007

Scientists develop method to track immune system enzyme in live animals

Scientists supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) at the National Institutes of Health have created two mouse strains that will permit researchers to trace, in a live animal, the activity of an enzyme believed to play a crucial role both in the normal immune response as well as autoimmunity and B cell tumor development.

18 May 2007

Sally speaks on osteoporosis story on Capitol Hill

The Society for Women's Health Research and the National Osteoporosis Foundation held a briefing on Capitol Hill to inform lawmakers about recent advances in the prevention and treatment of osteoporosis.

18 May 2007

Merits and risks of postmenopausal hormone therapy

The study was categorized as a primary prevention trial for coronary heart disease, although the fact that mean age at recruitment was 63 years was not given enough importance at that time. WHI investigators concluded that hormone therapy (HT) was not cardioprotective, and, in fact, its riskbenefit ratio did not favor the use of postmenopausal hormones for prevention of chronic diseases.

17 May 2007